Santa Clara (California) [US], September 14 (ANI/PRNewswire): Advanced software tools continue to play a major role in 4,500+ rare disease drugs innovation and development, helping overcome challenges such as limited availability of patients and high-risk costs. To ensure successful remedies, patient screening must get simpler, cost-efficient, and faster to recruit.
\
\
